Filgotinib
GS-US-431-4567
Phase 3 small_molecule terminated
Quick answer
Filgotinib for Psoriatic Arthritis is a Phase 3 program (small_molecule) at Lakefront Biotherapeutics NV with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Lakefront Biotherapeutics NV
- Indication
- Psoriatic Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated